- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06981221
- Original Trial
PVI Predictors in Laparoscopic Hysterectomy
Predictors of Pleth Variability Index During Laparoscopically Assisted Vaginal Hysterectomy
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This prospective, single-center observational cohort study evaluates dynamic intraoperative changes in the Pleth Variability Index (PVI) in 50 adult female patients undergoing elective laparoscopically assisted vaginal hysterectomy (LAVH) at Wonkwang University Hospital.
After establishing euvolemia with a 500 mL Volulyte preload (Fresenius Kabi GmbH) over 30-50 minutes, no further intraoperative fluid boluses are given. Anesthesia is induced with propofol (2 mg/kg), fentanyl (1-2 μg/kg), and rocuronium (0.6 mg/kg), and maintained with sevoflurane or desflurane titrated to a bispectral index (BIS) of 40-60. Pneumoperitoneum is set at 12-15 mmHg, and positional maneuvers include 30° passive leg raising, 15° Trendelenburg, and 15° reverse Trendelenburg.
Monitoring devices and data acquisition:
- **Masimo Radical-7** pulse oximeter (PVI, perfusion index [PI])
- **Invasive arterial line** (mean arterial pressure [MAP])
- **BIS sensor** (BIS)
- **Skin temperature probe** (forearm, °C) calibrated pre-case
Measurements are recorded at six standardized time points (baseline; post-induction; post-passive leg raising; post-pneumoperitoneum; post-Trendelenburg; post-reverse Trendelenburg). Continuous waveforms are averaged over 30 s epochs.
Primary endpoint is the absolute change in PVI (ΔPVI) relative to baseline. Secondary analyses include:
- Multivariable logistic regression for predictors of ΔPVI ≥ 5%
- Multivariable linear regression for continuous ΔPVI prediction
- Correlation analyses of ΔPVI with intraabdominal pressure (mmHg) and body mass index (kg/m²)
- Sensitivity analysis of PI reliability (intraclass correlation coefficient) across skin temperature thresholds
- Descriptive statistics for frequency of vasopressor (ephedrine) use
All analyses are performed using SPSS v29.0 with p < 0.05 considered statistically significant (Bonferroni correction applied for repeated measures).
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Jeollabuk-do
-
Iksan, Jeollabuk-do, South Korea, 54538
- Wonkwang University School of Medicine Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- adult females aged 19-70 years (American Society of Anesthesiologists physical status I-III) scheduled for elective LAVH.
Exclusion Criteria:
- emergency surgery, severe cardiac or pulmonary disease, renal failure, pregnancy, or conditions contraindicating fluid administration. Participants were consecutively recruited during preoperative consultations.
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
ΔPVI (Change in Pleth Variability Index)
Time Frame: Intraoperative period (~60-90 minutes)
|
Absolute change in PVI (%) at each of six intraoperative time points relative to baseline.
|
Intraoperative period (~60-90 minutes)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Proportion of patients with significant ΔPVI ≥ 5%
Time Frame: At any of the six predefined intraoperative time points: • Post-induction • Post-passive leg raising • Post-pneumoperitoneum • Post-Trendelenburg • Post-reverse Trendelenburg • End of surgery (within 60-90 minutes after induction of anesthesia)
|
Percentage of participants exhibiting a ΔPVI ≥ 5% at any intraoperative time point.
|
At any of the six predefined intraoperative time points: • Post-induction • Post-passive leg raising • Post-pneumoperitoneum • Post-Trendelenburg • Post-reverse Trendelenburg • End of surgery (within 60-90 minutes after induction of anesthesia)
|
|
Effect of intraabdominal pressure on ΔPVI
Time Frame: At post-pneumoperitoneum and post-Trendelenburg time points (20-45 minutes after anesthesia induction)
|
Correlation coefficient (r) between intraabdominal pressure (mmHg) and magnitude of ΔPVI.with magnitude of ΔPVI during pneumoperitoneum and Trendelenburg position.
Multivariable linear regression is used.
|
At post-pneumoperitoneum and post-Trendelenburg time points (20-45 minutes after anesthesia induction)
|
|
Effect of body mass index on ΔPVI
Time Frame: ΔPVI measured at post-pneumoperitoneum and post-Trendelenburg time points (20-45 minutes after anesthesia induction)
|
Correlation coefficient (r) between BMI (kg/m²) and magnitude of ΔPVI.measurements during LAVH.
Data analyzed using subgroup comparison between stable and decreased skin temperature conditions.
|
ΔPVI measured at post-pneumoperitoneum and post-Trendelenburg time points (20-45 minutes after anesthesia induction)
|
|
Change in mean arterial pressure (MAP)
Time Frame: MAP measured at six predefined intraoperative time points: • Baseline • Post-induction • Post-passive leg raising • Post-pneumoperitoneum • Post-Trendelenburg • Post-reverse Trendelenburg (Total duration: ~90 minutes after anesthesia induction)
|
Absolute change in MAP (mmHg) at the six predefined time points.
|
MAP measured at six predefined intraoperative time points: • Baseline • Post-induction • Post-passive leg raising • Post-pneumoperitoneum • Post-Trendelenburg • Post-reverse Trendelenburg (Total duration: ~90 minutes after anesthesia induction)
|
|
Change in perfusion index (PI)
Time Frame: MAP measured at six predefined intraoperative time points: • Baseline • Post-induction • Post-passive leg raising • Post-pneumoperitoneum • Post-Trendelenburg • Post-reverse Trendelenburg (Total duration: ~90 minutes after anesthesia induction)
|
Absolute change in PI (unitless) at the six predefined time points.
|
MAP measured at six predefined intraoperative time points: • Baseline • Post-induction • Post-passive leg raising • Post-pneumoperitoneum • Post-Trendelenburg • Post-reverse Trendelenburg (Total duration: ~90 minutes after anesthesia induction)
|
|
Change in bispectral index (BIS)
Time Frame: MAP measured at six predefined intraoperative time points: • Baseline • Post-induction • Post-passive leg raising • Post-pneumoperitoneum • Post-Trendelenburg • Post-reverse Trendelenburg (Total duration: ~90 minutes after anesthesia induction)
|
Absolute change in BIS (unitless) at the six predefined time points.
|
MAP measured at six predefined intraoperative time points: • Baseline • Post-induction • Post-passive leg raising • Post-pneumoperitoneum • Post-Trendelenburg • Post-reverse Trendelenburg (Total duration: ~90 minutes after anesthesia induction)
|
|
Influence of skin temperature on PI reliability
Time Frame: MAP measured at six predefined intraoperative time points: • Baseline • Post-induction • Post-passive leg raising • Post-pneumoperitoneum • Post-Trendelenburg • Post-reverse Trendelenburg (Total duration: ~90 minutes after anesthesia induction)
|
Difference in intraclass correlation coefficient of PI measurements between stable (≤ ± 1 °C) and decreased (> 1 °C drop) skin temperature conditions.
|
MAP measured at six predefined intraoperative time points: • Baseline • Post-induction • Post-passive leg raising • Post-pneumoperitoneum • Post-Trendelenburg • Post-reverse Trendelenburg (Total duration: ~90 minutes after anesthesia induction)
|
|
Frequency of vasopressor use
Time Frame: MAP measured at six predefined intraoperative time points: • Baseline • Post-induction • Post-passive leg raising • Post-pneumoperitoneum • Post-Trendelenburg • Post-reverse Trendelenburg (Total duration: ~90 minutes after anesthesia induction)
|
Number and percentage of patients requiring ephedrine bolus due to MAP < 70 mmHg during the observation period.
|
MAP measured at six predefined intraoperative time points: • Baseline • Post-induction • Post-passive leg raising • Post-pneumoperitoneum • Post-Trendelenburg • Post-reverse Trendelenburg (Total duration: ~90 minutes after anesthesia induction)
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Cheol Lee, M.D.,Ph.D, Wonkwang University Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- Wonkwang UH19
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.